NEW

The U.S. Food and Drug Administration (FDA) issued the revised draft guidance, “Addressing Misinformation About Medical Devices…

During a recent House of Representatives Energy and Commerce subcommittee hearing, the Center for Medicare and Medicaid Innovation…

In a recent episode of "Oncology Update," Dr. John Marshall from Georgetown University provided a comprehensive review of the…

The upcoming MEDX Primary Care Meeting is an essential event for primary care providers looking to stay at the forefront of their…

Bloomberg recently wrote about a push by the rare disease community for changes in the Inflation Reduction Act’s drug…

Recently, the House of Representatives Energy and Commerce Committee and Subcommittee on Oversight and Investigations held a…

Recently, the Centers for Medicare and Medicaid Services (CMS) issued draft guidance for the second cycle of negotiations for the…

The United States Centers for Medicare and Medicaid Services (CMS) recently proposed a new mandatory Medicare payment model to…

Recently, the Centers for Medicare and Medicaid Services (CMS) released a report that provides insight into clinicians’…

A new final rule promulgated by the United States Food and Drug Administration (FDA) is now in effect, amending regulations…